11. Loss‐of‐function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype. (1st May 2019) Authors: Maruthappu, T.; Posafalvi, A.; Castelletti, S.; Delaney, P.J.; Syrris, P.; O'Toole, E.A.; Green, K.J.; Elliott, P.M.; Lambiase, P.D.; Tinker, A.; McKenna, W.J.; Kelsell, D.P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Loss‐of‐function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype. (2nd January 2019) Authors: Maruthappu, T.; Posafalvi, A.; Castelletti, S.; Delaney, P.J.; Syrris, P.; O'Toole, E.A.; Green, K.J.; Elliott, P.M.; Lambiase, P.D.; Tinker, A.; McKenna, W.J.; Kelsell, D.P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Loss‐of‐function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype4. (2nd January 2019) Authors: Maruthappu, T.; Posafalvi, A.; Castelletti, S.; Delaney, P.J.; Syrris, P.; O'Toole, E.A.; Green, K.J.; Elliott, P.M.; Lambiase, P.D.; Tinker, A.; McKenna, W.J.; Kelsell, D.P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?. (14th July 2021) Authors: Steele, L.; Lee, H. L.; Maruthappu, T.; O'Toole, E. A. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?. (1st October 2021) Authors: Steele, L.; Lee, H. L.; Maruthappu, T.; O'Toole, E. A. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 7(2021) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗